{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:49:01Z","timestamp":1757627341899,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The incidence of oropharyngeal cancers is increasing due to human papilloma virus (HPV); however, this phenomenon does not explain the rising incidence of oral cancers, for which the reason remains unknown. These cancers are typically diagnosed at an advanced stage, which adversely affects the prognosis. Improved methods for early detection, such as blood-based biomarkers, could significantly improve patient outcomes. We investigated quantitative and qualitative differences in serum protein N-glycosylation between patients with oral squamous cell carcinoma (OSCC) and healthy controls using label-free mass spectrometry-based proteomics and N-glycopeptidomics. Twenty-five N-glycopeptides from seven different proteins were identified, all glycoforms associated with abundant serum proteins. While protein expression differences between OSCC and controls were modest (\u2264\u20092-fold), certain glycoforms showed pronounced changes, with fold differences ranging from 7 to 33, highlighting their role as potential biomarkers. Importantly, the glycosylation patterns observed in OSCC were distinct from those previously reported in oropharyngeal cancer, suggesting a level of disease specificity. These observations support the future potential of N-glycosylation changes to serve as cancer-specific biomarkers.<\/jats:p>","DOI":"10.1038\/s41598-025-17339-w","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:22:45Z","timestamp":1756768965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease-specific N-glycopeptides in serum of patients with oral squamous cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Tiialotta","family":"Tohmola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakari","family":"Joenv\u00e4\u00e4r\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvi","family":"Sil\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"17339_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5114\/wo.2017.68628","volume":"21","author":"P Tandon","year":"2017","unstructured":"Tandon, P., Dadhich, A., Saluja, H., Bawane, S. & Sachdeva, S. The prevalence of squamous cell carcinoma in different sites of oral cavity at our rural health care centre in loni, Maharashtra - a retrospective 10-year study. Contemp. Oncol. (Pozn). 21, 178\u2013183. https:\/\/doi.org\/10.5114\/wo.2017.68628 (2017).","journal-title":"Contemp. Oncol. (Pozn)"},{"key":"17339_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1601-0825.2009.01563.x","volume":"15","author":"C Scully","year":"2009","unstructured":"Scully, C. & Bagan, J. Oral squamous cell carcinoma: overview of current Understanding of aetiopathogenesis and clinical implications. Oral Dis. 15, 388\u2013399. https:\/\/doi.org\/10.1111\/j.1601-0825.2009.01563.x (2009).","journal-title":"Oral Dis."},{"key":"17339_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"17339_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3109\/00016489.2011.649146","volume":"132","author":"K Annertz","year":"2012","unstructured":"Annertz, K., Anderson, H., Palm\u00e9r, K. & Wennerberg, J. The increase in incidence of cancer of the tongue in the nordic countries continues into the twenty-first century. Acta Otolaryngol. 132, 552\u2013557. https:\/\/doi.org\/10.3109\/00016489.2011.649146 (2012).","journal-title":"Acta Otolaryngol."},{"key":"17339_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10585-019-09994-x","volume":"36","author":"M Elhousiny","year":"2019","unstructured":"Elhousiny, M., Miller, K., Ariyawadana, A. & Nimmo, A. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review. Clin. Exp. Metastasis. 36, 481\u2013492 (2019).","journal-title":"Clin. Exp. Metastasis"},{"key":"17339_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/1097-0142(19920701)70:1<14::AID-CNCR2820700103>3.0.CO;2-S","volume":"70","author":"GL Day","year":"1992","unstructured":"Day, G. L. & Blot, W. J. Second primary tumors in patients with oral cancer. Cancer 70, 14\u201319  (1992).","journal-title":"Cancer"},{"key":"17339_CR7","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00784-021-04186-y","volume":"26","author":"S Zittel","year":"2022","unstructured":"Zittel, S. et al. Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study. Clin. Oral Investig. 26, 2055\u20132064. https:\/\/doi.org\/10.1007\/s00784-021-04186-y (2022).","journal-title":"Clin. Oral Investig"},{"key":"17339_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/(SICI)1097-0347(200001)22:1<34::AID-HED6>3.0.CO;2-3","volume":"22","author":"GJ Schwartz","year":"2000","unstructured":"Schwartz, G. J., Mehta, R. H., Wenig, B. L., Shaligram, C. & Portugal, L. G. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck. 22, 34\u201341.  (2000).","journal-title":"Head Neck"},{"key":"17339_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/10408369309084666","volume":"30","author":"I Brockhausen","year":"1993","unstructured":"Brockhausen, I. Clinical aspects of glycoprotein biosynthesis. Crit. Rev. Clin. Lab. Sci. 30, 65\u2013151. https:\/\/doi.org\/10.3109\/10408369309084666 (1993).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"17339_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","volume":"33","author":"F Clerc","year":"2016","unstructured":"Clerc, F. et al. Human plasma protein N-glycosylation. Glycoconj. J. 33, 309\u2013343. https:\/\/doi.org\/10.1007\/s10719-015-9626-2 (2016).","journal-title":"Glycoconj. J."},{"key":"17339_CR11","doi-asserted-by":"publisher","first-page":"35478","DOI":"10.18632\/oncotarget.8155","volume":"7","author":"J Munkley","year":"2016","unstructured":"Munkley, J. & Elliott, D. J. Hallmarks of glycosylation in cancer. Oncotarget 7, 35478\u201335489. https:\/\/doi.org\/10.18632\/oncotarget.8155 (2016).","journal-title":"Oncotarget"},{"key":"17339_CR12","doi-asserted-by":"publisher","first-page":"011","DOI":"10.4172\/jpb.1000004","volume":"1","author":"T Tran","year":"2008","unstructured":"Tran, T., Nguyen, T., Nguyen, B. & Phan, V. Changes of serum glycoproteins in lung cancer patients. J. Proteom. Bioinform. 1, 011\u2013016 (2008).","journal-title":"J. Proteom. Bioinform"},{"key":"17339_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrurol.2012.258","volume":"10","author":"S Gilgunn","year":"2013","unstructured":"Gilgunn, S., Conroy, P. J., Saldova, R. & Rudd, P. M. O\u2019kennedy, R. J. Aberrant PSA glycosylation\u2014a sweet predictor of prostate cancer. Nat. Reviews Urol. 10, 99\u2013107 (2013).","journal-title":"Nat. Reviews Urol."},{"key":"17339_CR14","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.7150\/thno.15226","volume":"6","author":"E Llop","year":"2016","unstructured":"Llop, E. et al. Improvement of prostate cancer diagnosis by detecting PSA Glycosylation-Specific changes. Theranostics 6, 1190\u20131204. https:\/\/doi.org\/10.7150\/thno.15226 (2016).","journal-title":"Theranostics"},{"key":"17339_CR15","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.1038\/s41598-019-48821-x","volume":"9","author":"Y Egashira","year":"2019","unstructured":"Egashira, Y. et al. Establishment and characterization of a fucosylated \u03b1-fetoprotein-specific monoclonal antibody: a potential application for clinical research. Sci. Rep. 9, 12359 (2019).","journal-title":"Sci. Rep."},{"key":"17339_CR16","doi-asserted-by":"publisher","unstructured":"Schmelter, C. et al. Lectin-based affinity enrichment and characterization of N-glycoproteins from human tear film by mass spectrometry. Molecules  https:\/\/doi.org\/10.3390\/molecules28020648 (2023).","DOI":"10.3390\/molecules28020648"},{"key":"17339_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1074\/mcp.M400015-MCP200","volume":"3","author":"TZ Kristiansen","year":"2004","unstructured":"Kristiansen, T. Z. et al. A proteomic analysis of human bile. Mol. Cell. Proteom. 3, 715\u2013728. https:\/\/doi.org\/10.1074\/mcp.M400015-MCP200 (2004).","journal-title":"Mol. Cell. Proteom."},{"issue":".013649","key":"17339_CR18","doi-asserted-by":"publisher","first-page":"M111","DOI":"10.1074\/mcp.M111.013649","volume":"11","author":"A Halim","year":"2012","unstructured":"Halim, A., Nilsson, J., R\u00fcetschi, U., Hesse, C. & Larson, G. Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD. Mol. Cell. Proteom. 11 (.013649), M111. https:\/\/doi.org\/10.1074\/mcp.M111.013649 (2012).","journal-title":"Mol. Cell. Proteom."},{"key":"17339_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1096\/fba.2023-00066","volume":"6","author":"A Dickinson","year":"2024","unstructured":"Dickinson, A. et al. Altered microheterogeneity at several N-glycosylation sites in OPSCC in constant protein expression conditions. FASEB Bioadv. 6, 26\u201339. https:\/\/doi.org\/10.1096\/fba.2023-00066 (2024).","journal-title":"FASEB Bioadv"},{"key":"17339_CR20","doi-asserted-by":"publisher","first-page":"e1800061","DOI":"10.1002\/prca.201800061","volume":"12","author":"M Saraswat","year":"2018","unstructured":"Saraswat, M. et al. Tongue cancer patients can be distinguished from healthy controls by specific N-Glycopeptides found in serum. Proteom. Clin. Appl. 12, e1800061. https:\/\/doi.org\/10.1002\/prca.201800061 (2018).","journal-title":"Proteom. Clin. Appl."},{"key":"17339_CR21","doi-asserted-by":"publisher","unstructured":"Bellis, S. L., Reis, C. A., Varki, A., Kannagi, R. & Stanley, P.  Essentials of glycobiology. In Cold Spring Harbor Laboratory Press Copyright \u00a9 2022 The Consortium of Glycobiology Editors, La Jolla, California  (eds A. Varki et al.) 631\u2013644  https:\/\/doi.org\/10.1101\/glycobiology.4e.47  (Cold Spring Harbor Laboratory Press, 2022).","DOI":"10.1101\/glycobiology.4e.47"},{"key":"17339_CR22","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1039\/D0AN00369G","volume":"145","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. A comprehensive analysis of subclass-specific IgG glycosylation in colorectal cancer progression by nanoLC-MS\/MS. Analyst 145, 3136\u20133147 (2020).","journal-title":"Analyst"},{"key":"17339_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner, M., Liu, J., Masterson, L. & Fenton, T. R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat. Rev. Clin. Oncol. 19, 306\u2013327. https:\/\/doi.org\/10.1038\/s41571-022-00603-7 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"17339_CR24","doi-asserted-by":"publisher","first-page":"104799","DOI":"10.1016\/j.oraloncology.2020.104799","volume":"107","author":"A Almangush","year":"2020","unstructured":"Almangush, A. et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 107, 104799. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104799 (2020).","journal-title":"Oral Oncol."},{"key":"17339_CR25","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013d553. https:\/\/doi.org\/10.1093\/nar\/gkae1011 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17339-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T02:03:51Z","timestamp":1757469831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17339-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17339"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17339-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32276"}}